10x Genomics, Inc. — Director's Dealing 2022

Nov 23, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2022-11-22

Reporting Person: Hindson Benjamin J. (Director, See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-22	Class A Common Stock	S	359	$34.0657	Disposed	219715	Direct
2022-11-22	Class A Common Stock	S	915	$34.068	Disposed	218800	Direct
2022-11-22	Class A Common Stock	S	1087	$34.0679	Disposed	217713	Direct

Footnotes

F1: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.